Clinical Trial Update: SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is recruiting to evaluate SCG142 TCR-T cells targeting HPV-associated carcinomas across multiple HPV-related cancers, including cervica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Head and Neck Cancer
• Hpv-associated Cancer
• Penile Cancer
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• SCG142 TCR-T Cells (HPV-targeted T cell receptor-engineered T cells)

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Human Papillomavirus Associated Carcinomas, Cervical Cancer | Phase 1 | Status: RECRUITING